(571) 447-5500

Health Canada

Natural Health Products Regulation

Navigate Canada’s Natural Health Product requirements with greater confidence.

Health Canada Natural Health Products Regulation Premium Short Course

Presented by Paula Brock, Ph.D., MCSI

1-Hour Live Premium Short Course | $99

Understand a Regulatory Model That’s Very Different from the U.S.

Companies accustomed to the U.S. dietary supplement framework can encounter a very different regulatory model when entering the Canadian market.

In Canada, Natural Health Products (NHPs) are regulated as a subset of drugs rather than foods, and products require licensing before they can be sold.

In this fast-paced, practical session, EAS Consulting Group Senior Consultant Paula Brock, Ph.D., MCSI will demystify Health Canada’s Natural Health Product framework and explain what companies need to understand when evaluating products for the Canadian market.

You’ll explore how NHPs are defined and classified, how Health Canada monographs are used, what evidence is needed to support claims, how the Natural Product Number (NPN) licensing process works, and important labeling considerations.

What You’ll Learn

Health Canada’s NHP Regulatory Framework
Understand the role of the Natural and Non-prescription Health Products Directorate (NNHPD) and how Canada’s approach to NHPs differs from the U.S. dietary supplement model.

NHP Scope and Classification
Learn which types of ingredients and products can fall within the NHP framework and important exclusions.

Using Health Canada Monographs
Understand single-ingredient and product monographs and how conformity with established monographs can affect product licensing and evidence requirements.

Product Licensing and Natural Product Numbers (NPNs)
Explore the different licensing pathways and how product formulation, claims and deviations from established monographs can affect the level of Health Canada review.

Claims and Supporting Evidence
Learn how Health Canada takes a risk-based approach to NHP claims and how the strength of evidence should correspond to the type and risk level of the claim.

Clinical Trials
Understand when existing monographs and evidence may not be sufficient and when a Health Canada-authorized clinical trial may be necessary.

Labeling Requirements
Review key considerations for compliant NHP labeling, including required product information and other Canadian labeling requirements.

Who Should Attend

This short course is designed for:

  • Regulatory affairs professionals
  • Quality and compliance teams
  • R&D and formulation professionals
  • Marketing and labeling teams
  • Companies currently marketing Natural Health Products in Canada
  • U.S. dietary supplement companies evaluating expansion into the Canadian market

What You’ll Take Away

After this course, you’ll have a clearer understanding of:

  • How to determine where a product fits within Canada’s NHP regulatory framework
  • How monographs can affect product formulation, claims and licensing
  • How the Class I–III product licensing pathways differ
  • What evidence may be necessary to substantiate different types of claims
  • How the NPN process fits into Canadian market entry
  • Key labeling considerations when preparing an NHP for the Canadian market

New Dates to be Announced

Want to be the first to know of the new dates of the next seminar? Add your name and email address to be added to the notification list.

Live Virtual Training

This Premium Short Course will be conducted live through Zoom. A link to access the training will be provided to each registered participant prior to the course.

Cancellation Policy

EAS reserves the right to cancel the seminar if minimum participation has not been met two weeks prior to the start of the seminar.

Terms and Conditions

By submitting this form you will be joining the nearly 20,000 who receive the monthly EASeNews regulatory newsletter. Please note EAS never shares your information and you may unsubscribe at any time.

For More Information or Questions

Contact Jessica Lloyd at (571) 447-5508 or trainings@easconsultinggroup.com

About the Presenter

Paula Brock, Ph.D., MCSI

EAS Consulting Group Independent Consultant

Paula BrockDr. Paula Brock is an independent consultant with EAS Consulting Group, providing scientific and regulatory expertise to clients in the food, dietary supplement, and cosmetic industries. She collaborates with EAS consultants and clients on label compliance reviews, marketing material reviews for FDA and FTC compliance, and claims substantiation.

Her scientific services include clinical study design, data analysis, herb–drug interaction assessments, product formulation, ingredient safety and efficacy evaluations, ingredient monograph development, safety opinions, and adverse event investigations. She also develops substantiated claims and scientific presentations for marketing purposes and serves on Generally Recognized as Safe (GRAS) and New Dietary Ingredient (NDI) expert panels.

Dr. Brock has 22 years of experience in pharmacology and toxicology, including 13 years in academia focused on clinical and preclinical research, neuroscience, analytical and clinical pharmacology, molecular biology, and personalized medicine. Her nine years in industry have expanded her expertise to include U.S. and international regulations for dietary supplements and cosmetics, herb–drug interactions, adverse event investigations, safety and efficacy claims substantiation, product formulation, and public speaking. She has held senior director positions in scientific and regulatory affairs within the U.S. dietary supplement and cosmetic industries.

Dr. Brock holds a Ph.D. in Pharmacology and Toxicology from the University of Utah, a Master of Science in Clinical Investigation from Howard Hughes Medical Institute, and bachelor’s degrees in chemistry and pharmacy.

Posted in Dietary Supplements, Seminar.